glycine has been researched along with Angiitis in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
"We investigated the efficacy of sivelestat sodium hydrate (SSH) as a treatment for Kawasaki disease, and its pharmacological action sites, in mice with Candida albicans water-soluble fraction-induced vasculitis." | 8.12 | Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis. ( Banno-Terada, R; Endo, M; Fujii, T; Kohno, T; Maekawa, A; Mamiya, R; Nagi-Miura, N; Ohno, N; Takada, M; Takagaki, N; Tanaka, A; Tsuji, T; Yamada, A; Yoshida, Y, 2022) |
"Ixazomib is a second-generation proteasome inhibitor that has been approved in the combination treatment of multiple myeloma and is currently under clinical investigation for the management of Waldenstrom's macroglobulinemia." | 5.48 | Ixazomib-induced cutaneous necrotizing vasculitis. ( Alloo, A; Castillo, JJ; Granter, SR; Jadeja, SM; Khosravi, H; LeBoeuf, NR; Richardson, PG, 2018) |
"We investigated the efficacy of sivelestat sodium hydrate (SSH) as a treatment for Kawasaki disease, and its pharmacological action sites, in mice with Candida albicans water-soluble fraction-induced vasculitis." | 4.12 | Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis. ( Banno-Terada, R; Endo, M; Fujii, T; Kohno, T; Maekawa, A; Mamiya, R; Nagi-Miura, N; Ohno, N; Takada, M; Takagaki, N; Tanaka, A; Tsuji, T; Yamada, A; Yoshida, Y, 2022) |
"Ixazomib is a second-generation proteasome inhibitor that has been approved in the combination treatment of multiple myeloma and is currently under clinical investigation for the management of Waldenstrom's macroglobulinemia." | 1.48 | Ixazomib-induced cutaneous necrotizing vasculitis. ( Alloo, A; Castillo, JJ; Granter, SR; Jadeja, SM; Khosravi, H; LeBoeuf, NR; Richardson, PG, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Yoshida, Y | 1 |
Banno-Terada, R | 1 |
Takada, M | 1 |
Fujii, T | 1 |
Takagaki, N | 1 |
Maekawa, A | 1 |
Tanaka, A | 1 |
Endo, M | 1 |
Yamada, A | 1 |
Mamiya, R | 1 |
Nagi-Miura, N | 1 |
Ohno, N | 1 |
Tsuji, T | 1 |
Kohno, T | 1 |
Kawagashira, Y | 1 |
Koike, H | 1 |
Kawabata, K | 1 |
Takahashi, M | 1 |
Ohyama, K | 1 |
Hashimoto, R | 1 |
Iijima, M | 1 |
Katsuno, M | 1 |
Sobue, G | 1 |
Alloo, A | 1 |
Khosravi, H | 1 |
Granter, SR | 1 |
Jadeja, SM | 1 |
Richardson, PG | 1 |
Castillo, JJ | 1 |
LeBoeuf, NR | 1 |
McCabe, P | 1 |
Agarwal, N | 1 |
Johnson, R | 1 |
4 other studies available for glycine and Angiitis
Article | Year |
---|---|
Sivelestat's effect on Candida albicans water-soluble fraction-induced vasculitis.
Topics: Animals; Candida albicans; Glycine; Humans; Intercellular Adhesion Molecule-1; Mice; Mucocutaneous L | 2022 |
Vasculitic Neuropathy Following Exposure to a Glyphosate-based Herbicide.
Topics: Aged; Glycine; Glyphosate; Herbicides; Humans; Male; Peripheral Nervous System Diseases; Vasculitis | 2017 |
Ixazomib-induced cutaneous necrotizing vasculitis.
Topics: Aged, 80 and over; Boron Compounds; Glycine; Humans; Male; Proteasome Inhibitors; Vasculitis | 2018 |
Small Bowel Ulcers From Cryocrystalglobulinemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boron Compounds; Bortezomib; Cryoglobulinemia | 2020 |